New hope for stubborn high blood pressure when other drugs fail

NCT ID NCT06344104

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new drug called baxdrostat can safely lower blood pressure in adults whose high blood pressure is not controlled by their current medications. About 326 participants, who are already taking two or more blood pressure drugs, will receive either baxdrostat or a placebo pill for 12 weeks. The main goal is to see if baxdrostat leads to a greater reduction in blood pressure compared to the dummy pill.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Bahía Blanca, 8000, Argentina
Research Site

CABA, C1426, Argentina
Research Site

Ciudad de Buenos Aires, C1419AHL, Argentina
Research Site

San Miguel de Tucumán, T4000ICL, Argentina
Research Site

San Nicolás de los Arroyos, B2900DPA, Argentina
Research Site

Coffs Harbour, 02450, Australia
Research Site

Gosford, 2250, Australia
Research Site

Hoppers Crossing, 3029, Australia
Research Site

Ipswich, 4305, Australia
Research Site

Baotou, 014010, China
Research Site

Beijing, 100029, China
Research Site

Beijing, 100044, China
Research Site

Bengbu, 233004, China
Research Site

Changde, 415000, China
Research Site

Changsha, 410015, China
Research Site

Changsha, 430033, China
Research Site

Changzhou, 272100, China
Research Site

Chengdu, 610041, China
Research Site

Chongqing, 400010, China
Research Site

Chongqing, 400014, China
Research Site

Chongqing, 400042, China
Research Site

Deyang, 618000, China
Research Site

Guangzhou, 510100, China
Research Site

Hangzhou, 310014, China
Research Site

Ha’erbin, 150001, China
Research Site

Hefei, 230601, China
Research Site

Heze, 274099, China
Research Site

Jiujiang, 332000, China
Research Site

Luoyang, 471000, China
Research Site

Meihekou, 135022, China
Research Site

Nanchang, 330009, China
Research Site

Nanchong, 637900, China
Research Site

Nanjing, 210009, China
Research Site

Panjin, 124009, China
Research Site

Sanya, 572000, China
Research Site

Shanghai, 200025, China
Research Site

Shanghai, 200040, China
Research Site

Shenyang, 110004, China
Research Site

Shenyang, 110016, China
Research Site

Taiyuan, 030024, China
Research Site

Tianjin, 300457, China
Research Site

Tianjin, China
Research Site

Wuhan, 430010, China
Research Site

Wuhan, 430022, China
Research Site

Wuhan, 430060, China
Research Site

Xianyang, 712000, China
Research Site

Xianyang, 750004, China
Research Site

Xuzhou, 221000, China
Research Site

Yangzhou, 225001, China
Research Site

Yinchuan, 750001, China
Research Site

Zigong, 643021, China
Research Site

Hong Kong, 00000, Hong Kong
Research Site

Hong Kong, Hong Kong
Research Site

Bangalore, 560 092, India
Research Site

Belagavi, 590016, India
Research Site

Chūōku, 103-0027, Japan
Research Site

Chūōku, 260-0804, Japan
Research Site

Hamamatsu, 430-0929, Japan
Research Site

Kagoshima, 890-8520, Japan
Research Site

Koga-shi, 306-0232, Japan
Research Site

Meguro-ku, 153-0051, Japan
Research Site

Minatoku, 108-0073, Japan
Research Site

Minokamo Shi, 505-8510, Japan
Research Site

Osaka, 530-8480, Japan
Research Site

Toshima-ku, 171-0014, Japan
Research Site

Tsukuba, 305-0861, Japan
Research Site

Yokohama, 236-0004, Japan
Research Site

Iloilo City, 5000, Philippines
Research Site

Quezon City, 1112, Philippines
Research Site

Ivanovo, 153012, Russia
Research Site

Moscow, 111539, Russia
Research Site

Moscow, 119991, Russia
Research Site

Moscow, 121552, Russia
Research Site

Moscow, 129327, Russia
Research Site

Saint Petersburg, 195067, Russia
Research Site

Saint Petersburg, 197341, Russia
Research Site

Seoul, 03080, South Korea
Research Site

Seoul, 03722, South Korea
Research Site

Seoul, 04763, South Korea
Research Site

Seoul, 05505, South Korea
Research Site

Ankara, 06800, Turkey (Türkiye)
Research Site

Ankara, 5000, Turkey (Türkiye)
Research Site

Cordaleo, 35575, Turkey (Türkiye)
Research Site

Edirne, 22030, Turkey (Türkiye)
Research Site

Kahramanmaraş, 46100, Turkey (Türkiye)
Research Site

Kayseri, 38039, Turkey (Türkiye)
Research Site

Kocaeli, 41380, Turkey (Türkiye)
Research Site

Mersin, 33343, Turkey (Türkiye)
Research Site

Can Tho, 900000, Vietnam
Research Site

Hanoi, 100000, Vietnam
Research Site

Ho Chi Minh City, 700000, Vietnam
Research Site

Hochiminh City, 700000, Vietnam
Research Site

Hochiminh, 70000, Vietnam

Conditions

Explore the condition pages connected to this study.

RESISTANT HYPERTENSION UNCONTROLLED HYPERTENSION